Proceedings of the International Symposium on Medroxyprogesterone Acetate, Geneva, Switzerland, February 24-26, 1982Francesco Cavalli |
Contents
Contents | 1 |
Experimental pharmacology and mechanism of antitumour | 45 |
Effects of medroxyprogesterone acetate on the development of di | 63 |
Copyright | |
45 other sections not shown
Common terms and phrases
activity adenocarcinoma administration advanced breast cancer analysis assay better binding blood carcinoma cells chemotherapy clinical combined compared complete concentrations cytosol daily decrease determined Discussion disease dosage drug duration effect endocrine endometrial carcinoma et al evaluable experience Figure findings given growth Gynecol high doses high-dose MPA higher histological hormonal hormonal therapy human increase indicated Italy lesions mean measured median medroxyprogesterone acetate MPA metastases methods mg/day months MPA plasma levels ng/ml numbers of patients objective observed obtained oestrogen Oncology oral ovarian partial patients patients treated performed period possible present Professor progesterone progesterone receptor progestin progression protein range received receptor regard regimen relation remission reported response rate route schedule serum shown shows side-effects significant stage status steroid subjective Table tamoxifen therapeutic therapy tients tion tissue treated treatment trial tumour values weeks women